<!DOCTYPE html>
<html lang="cs">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Relation Therapeutics oznÃ¡mila strategickou spoluprÃ¡ci s Novartis na vÃ½voj terapiÃ­ pro atopickÃ¡ onemocnÄ›nÃ­ | Marigold.cz Tech News</title>
    <meta name="description" content="Relation Therapeutics uzavÅ™ela vÃ­ceprogramovou strategickou spoluprÃ¡ci s Novartis na objev a pokroÄilÃ© vÃ½voj novÃ½ch cÃ­lÅ¯ pro atopickÃ¡ onemocnÄ›nÃ­. Firma obdrÅ¾Ã­ 5">
    <link rel="canonical" href="https://www.marigold.cz/tech-news/2025-12-09/relation-announces-strategic-collaboration-with-no/">
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; line-height: 1.6; color: #374151; background: #f3f4f6; }
        .container { max-width: 800px; margin: 0 auto; padding: 2rem; }
        .tech-news-article { background: white; border-radius: 12px; box-shadow: 0 4px 6px rgba(0,0,0,0.1); padding: 2rem; margin: 2rem 0; }
        .source-info { display: flex; align-items: center; gap: 0.75rem; margin-bottom: 1rem; flex-wrap: wrap; }
        .source-emoji { font-size: 1.5rem; }
        .source-name { font-weight: 600; color: #374151; }
        .importance-indicator { display: flex; gap: 2px; margin-left: auto; }
        .star { color: #fbbf24; font-size: 1.2rem; }
        .star.empty { color: #d1d5db; }
        .article-title { font-size: 2rem; font-weight: 700; line-height: 1.2; margin-bottom: 1rem; color: #111827; }
        .article-meta { display: flex; align-items: center; gap: 1rem; font-size: 0.875rem; color: #6b7280; margin-bottom: 1.5rem; }
        .category { padding: 0.25rem 0.75rem; border-radius: 1rem; font-weight: 500; font-size: 0.75rem; text-transform: uppercase; background: #e5e7eb; color: #374151; }
        .article-image { margin: 1.5rem 0; border-radius: 8px; overflow: hidden; }
        .article-image img { width: 100%; height: auto; display: block; }
        .article-content { font-size: 1.125rem; line-height: 1.7; margin-bottom: 2rem; }
        .article-content h2 { font-size: 1.5rem; margin: 1.5rem 0 1rem; color: #111827; }
        .article-content p { margin-bottom: 1rem; }
        .article-footer { border-top: 1px solid #e5e7eb; padding-top: 1.5rem; }
        .read-more-btn { display: inline-flex; align-items: center; gap: 0.5rem; padding: 0.75rem 1.5rem; background: #3b82f6; color: white; text-decoration: none; border-radius: 8px; font-weight: 500; }
        .read-more-btn:hover { background: #2563eb; }
        .original-title { margin-top: 1rem; color: #6b7280; font-size: 0.875rem; }
        .back-link { display: inline-block; margin-bottom: 1rem; color: #3b82f6; text-decoration: none; }
        .back-link:hover { text-decoration: underline; }
        .archive-notice { background: #fef3c7; border: 1px solid #f59e0b; border-radius: 8px; padding: 1rem; margin-bottom: 1rem; font-size: 0.875rem; color: #92400e; }
        @media (max-width: 640px) {
            .container { padding: 1rem; }
            .tech-news-article { padding: 1.5rem; margin: 1rem 0; }
            .article-title { font-size: 1.5rem; }
            .source-info { flex-direction: column; align-items: flex-start; }
            .importance-indicator { margin-left: 0; margin-top: 0.5rem; }
        }
    </style>
</head>
<body>
    <div class="container">
        <a href="/tech-news/" class="back-link">&larr; ZpÄ›t na Tech News</a>

        <div class="archive-notice">
            Tento ÄlÃ¡nek je z archivu. Byl publikovÃ¡n 09.12.2025.
        </div>

        <article class="tech-news-article">
            <header>
                <div class="source-info">
                    <span class="source-emoji">ğŸ“°</span>
                    <span class="source-name">GlobeNewswire</span>
                    <div class="importance-indicator">
                        <span class="star">â˜…</span><span class="star">â˜…</span><span class="star">â˜…</span><span class="star">â˜…</span><span class="star empty">â˜†</span>
                    </div>
                </div>

                <h1 class="article-title">Relation Therapeutics oznÃ¡mila strategickou spoluprÃ¡ci s Novartis na vÃ½voj terapiÃ­ pro atopickÃ¡ onemocnÄ›nÃ­</h1>

                <div class="article-meta">
                    <time datetime="2025-12-09T08:00:00+00:00">09.12.2025</time>
                    <span class="category">biotechnologie</span>
                </div>
            </header>

            
            <div class="article-image">
                <img src="https://ml-eu.globenewswire.com/Resource/Download/cf260ee4-7c41-4306-b2c4-28320acc9186" alt="Relation Therapeutics oznÃ¡mila strategickou spoluprÃ¡ci s Novartis na vÃ½voj terapiÃ­ pro atopickÃ¡ onemocnÄ›nÃ­" loading="lazy">
            </div>
        

            <div class="article-content">
                <h3>Souhrn</h3>
<p>Relation Therapeutics, londÃ½nskÃ¡ spoleÄnost zamÄ›Å™enÃ¡ na objev lÃ©kÅ¯ s vyuÅ¾itÃ­m umÄ›lÃ© inteligence, oznÃ¡mila strategickou spoluprÃ¡ci s farmaceutickÃ½m gigantem Novartis. CÃ­lem je identifikace a validace novÃ½ch molekulÃ¡rnÃ­ch cÃ­lÅ¯ pro atopickÃ¡ onemocnÄ›nÃ­, jako je ekzÃ©m nebo astma, kterÃ¡ postihujÃ­ stovky milionÅ¯ lidÃ­ na svÄ›tÄ›. Relation obdrÅ¾Ã­ 55 milionÅ¯ dolarÅ¯ v podobÄ› pÅ™edem placenÃ© ÄÃ¡stky, investice do akciÃ­ a financovÃ¡nÃ­ vÃ½zkumu a vÃ½voje, s potenciÃ¡lem dalÅ¡Ã­ch 1,7 miliardy dolarÅ¯ v milnÃ­cÃ­ch a licenÄnÃ­mi poplatky.</p>
<h3>KlÃ­ÄovÃ© body</h3>
<ul>
<li>FinanÄnÃ­ podmÃ­nky: 55 milionÅ¯ dolarÅ¯ pÅ™edem, milnÃ­ky z pÅ™edklinickÃ½ch, vÃ½vojovÃ½ch, regulaÄnÃ­ch a komerÄnÃ­ch fÃ¡zÃ­ aÅ¾ 1,7 miliardy dolarÅ¯, stupÅˆovitÃ© licenÄnÃ­ poplatky z ÄistÃ½ch trÅ¾eb.</li>
<li>Technologie Relation: Platforma Lab-in-the-Loop kombinuje AI s multi-omickÃ½mi daty z pacientÅ¯ a proprietÃ¡rnÃ­mi experimentÃ¡lnÃ­mi systÃ©my pro identifikaci kauzÃ¡lnÃ­ch genÅ¯.</li>
<li>Role stran: Relation provede observaÄnÃ­ studie pro tvorbu funkÄnÃ­ch bunÄ›ÄnÃ½ch atlasÅ¯ pÅ™Ã­mo z tkÃ¡nÄ› pacientÅ¯; Novartis pÅ™inese expertizu v imunodermatologii.</li>
<li>CÃ­lovÃ¡ onemocnÄ›nÃ­: AtopickÃ¡ onemocnÄ›nÃ­ zpÅ¯sobenÃ¡ poruchou imunitnÃ­ regulace.</li>
<li>CitÃ¡t CEO Davida Roblina: Technologie Relation porovnÃ¡vÃ¡ molekulÃ¡rnÃ­ drÃ¡hy v nemocnÃ© a zdravÃ© tkÃ¡ni pro objev novÃ½ch terapiÃ­.</li>
</ul>
<h3>Podrobnosti</h3>
<p>Relation Therapeutics je startup zaloÅ¾enÃ½ na pokroÄilÃ© aplikaci umÄ›lÃ© inteligence v oblasti objevovÃ¡nÃ­ lÃ©kÅ¯. Jeho platforma Lab-in-the-Loop integruje stÃ¡vajÃ­cÃ­ AI modely s daty z multi-omiky â€“ tedy komplexnÃ­mi biologickÃ½mi daty z genomu, transkriptomu, proteinomu a dalÅ¡Ã­ch ÃºrovnÃ­ â€“ zÃ­skanÃ½mi z tkÃ¡nÃ­ pacientÅ¯. Tyto data se kombinujÃ­ s proprietÃ¡rnÃ­mi experimentÃ¡lnÃ­mi systÃ©my, kterÃ© umoÅ¾ÅˆujÃ­ testovÃ¡nÃ­ hypotÃ©z o kauzÃ¡lnÃ­ch genech pÅ™Ã­mo v laboratornÃ­ch podmÃ­nkÃ¡ch. Tento pÅ™Ã­stup, oznaÄovanÃ½ jako lab-in-the-loop, umoÅ¾Åˆuje iterativnÃ­ zlepÅ¡ovÃ¡nÃ­ predikcÃ­ AI na zÃ¡kladÄ› reÃ¡lnÃ½ch experimentÃ¡lnÃ­ch vÃ½sledkÅ¯, coÅ¾ sniÅ¾uje riziko nesprÃ¡vnÃ½ch hypotÃ©z.</p>
<p>V rÃ¡mci spoluprÃ¡ce s Novartis, jednÃ­m z nejvÄ›tÅ¡Ã­ch hrÃ¡ÄÅ¯ v farmaceutickÃ©m prÅ¯myslu s hlubokÃ½mi znalostmi v oblasti imunodermatologie, Relation povede observaÄnÃ­ studie. Ty generujÃ­ funkÄnÃ­ bunÄ›ÄnÃ© atlasy z tkÃ¡nÄ› pacientÅ¯ s atopickÃ½mi onemocnÄ›nÃ­mi, coÅ¾ poskytuje bezprecedentnÃ­ rozliÅ¡enÃ­ stavu nemoci u lidÃ­. Na rozdÃ­l od tradiÄnÃ­ch in silico modelÅ¯, kterÃ© pracujÃ­ pouze s daty, tento pÅ™Ã­stup zajiÅ¡Å¥uje validaci cÃ­lÅ¯ pÅ™ed vstupem do klinickÃ½ch studiÃ­, ÄÃ­mÅ¾ minimalizuje riziko selhÃ¡nÃ­ v pozdnÃ­ch fÃ¡zÃ­ch vÃ½voje â€“ problÃ©m, kterÃ½ stojÃ­ farmaceutickÃ½ prÅ¯mysl miliardy dolarÅ¯ roÄnÄ›.</p>
<p>Novartis pÅ™inese svÃ© schopnosti ve vÃ½voji a komercializaci lÃ©kÅ¯, zejmÃ©na v oblasti imunitnÃ­ch a koÅ¾nÃ­ch onemocnÄ›nÃ­. SpoluprÃ¡ce je multi-programovÃ¡, coÅ¾ znamenÃ¡, Å¾e se vztahuje na vÃ­ce projektÅ¯ souÄasnÄ›, a zamÄ›Å™uje se na first-in-class cÃ­le â€“ tedy novÃ© mechanismy, kterÃ© nemajÃ­ existujÃ­cÃ­ konkurenci. Datum oznÃ¡menÃ­ je 9. prosince 2025, coÅ¾ naznaÄuje, Å¾e prÃ¡ce jiÅ¾ probÃ­hÃ¡.</p>
<h3>ProÄ je to dÅ¯leÅ¾itÃ©</h3>
<p>Tato spoluprÃ¡ce podtrhuje rostoucÃ­ roli umÄ›lÃ© inteligence v biotechnologiÃ­ch, kde tradiÄnÃ­ screening tisÃ­cÅ¯ slouÄenin trvÃ¡ roky, zatÃ­mco AI umoÅ¾Åˆuje rychlejÅ¡Ã­ identifikaci relevantnÃ­ch cÃ­lÅ¯ na zÃ¡kladÄ› reÃ¡lnÃ½ch dat z pacientÅ¯. AtopickÃ¡ onemocnÄ›nÃ­ postihujÃ­ pÅ™es 300 milionÅ¯ lidÃ­ globÃ¡lnÄ› a aktuÃ¡lnÃ­ lÃ©Äba je Äasto nedostateÄnÃ¡, s vysokÃ½m rizikem relapsÅ¯. Pokud uspÄ›je, mÅ¯Å¾e vÃ©st k terapiÃ­m mÄ›nÃ­cÃ­m standard pÃ©Äe.</p>
<p>Pro AI prÅ¯mysl to znamenÃ¡ validaci pÅ™Ã­stupÅ¯ jako lab-in-the-loop, kterÃ© pÅ™ekonÃ¡vajÃ­ limity ÄistÄ› datovÃ½ch modelÅ¯ tÃ­m, Å¾e integrujÃ­ fyzickÃ© experimenty. Pro Relation to pÅ™edstavuje nejen kapitÃ¡l, ale i pÅ™Ã­stup k NovartisovÃ½m datÅ¯m a infrastruktuÅ™e, coÅ¾ zvyÅ¡uje Å¡ance na ÃºspÄ›ch. V Å¡irÅ¡Ã­m kontextu ukazuje, jak AI firmy expandujÃ­ do pharma, kde selhÃ¡nÃ­ je drahÃ©, ale ÃºspÄ›chy pÅ™inÃ¡Å¡ejÃ­ obrovskÃ© vÃ½nosy. Kriticky Å™eÄeno, ÃºspÄ›ch zÃ¡visÃ­ na kvalitÄ› dat z pacientÅ¯ a schopnosti AI odliÅ¡it kauzÃ¡lnÃ­ od korelaÄnÃ­ch vztahÅ¯, coÅ¾ zÅ¯stÃ¡vÃ¡ vÃ½zvou i pro nejlepÅ¡Ã­ systÃ©my.</p>
<hr />
<p><a href="https://www.globenewswire.com/news-release/2025/12/09/3202076/0/en/Relation-announces-strategic-collaboration-with-Novartis-to-advance-therapeutics-for-atopic-diseases.html">ÄŒÃ­st pÅ¯vodnÃ­ ÄlÃ¡nek</a></p>
<p><strong>Zdroj:</strong> ğŸ“° GlobeNewswire</p>
            </div>

            <footer class="article-footer">
                <a href="https://www.globenewswire.com/news-release/2025/12/09/3202076/0/en/Relation-announces-strategic-collaboration-with-Novartis-to-advance-therapeutics-for-atopic-diseases.html" target="_blank" rel="noopener" class="read-more-btn">
                    ÄŒÃ­st pÅ¯vodnÃ­ ÄlÃ¡nek &rarr;
                </a>

                <div class="original-title"><small>PÅ¯vodnÃ­ nÃ¡zev: Relation announces strategic collaboration with Novartis to advance therapeutics for atopic diseases</small></div>
            </footer>
        </article>

        <p style="text-align: center; color: #6b7280; font-size: 0.875rem; margin-top: 2rem;">
            &copy; 2025 <a href="https://www.marigold.cz" style="color: #3b82f6;">Marigold.cz</a>
        </p>
    </div>
</body>
</html>
